Michel “Mike” Morency

I help life science innovators turn ideas into defensible, deal‑ready assets. A registered U.S. patent attorney with a Ph.D. in Neuroscience, I bring 30+ years of experience advising biotech, pharma, diagnostics, medtech and med device companies—from first‑in funding through commercialization and exit. I design and execute IP strategies that protect core value, accelerate partnering, and withstand diligence. WHAT I DO • Build cost‑effective patent portfolios aligned to clinical and commercial endpoints. • Deliver patentability, freedom‑to‑operate and non‑infringement opinions; manage post‑grant challenges. • Structure and negotiate licenses, sponsored research, collaborations, and supply/manufacturing agreements. • Guide transactions—due diligence for financings and M&A; help teams tell a crisp IP story that drives valuation. FOCUS AREAS Neuroscience and beyond—including drug delivery to the CNS; small‑molecule, biologic and nucleic acid therapeutics; diagnostics; and medical devices. I’ve represented universities, nonprofits, early‑stage ventures and Fortune 500 companies, which gives me a 360° view of what each side needs to close a deal. PHILOSOPHY Great IP is an important business tool. But a patent without a business strategy is just a stack of paper. I translate complex science into IP and contracts that create leverage—prioritizing speed, clarity, and capital efficiency. If you’re preparing for financing, partnering or an exit—and want your IP doing more than ‘protecting’—let’s connect. REPRESENTATIVE PATENT MATTERS: US 12,331,088 | Methods for the Treatment of an ARDS. (Assignee: Revolo Therapeutics) US 12,357,728 | Conformal Coating of Cells for Immunoisolation. (Assignee: Sernova Biotherapeutics) WO 2024/058812 | Vigabatrin Liquid Pharmaceutical Composition. (Applicant: Pyros Pharmaceuticals) US 11,986,616 | Access Port System for Intrathecal Drug Delivery with Self-Adjusting Catheter Length. (Applicant: IMOTIK BioSolutions)